Editorial

DOI: 10.4244/EIJ-E-25-00005

Unveiling the coronary acetylcholine test: can it help us predict future cardiovascular events?

Javier Escaned1, MD, PhD; Luca Paolucci1, MD

In 2025, we have good reasons to consider acetylcholine (ACh) testing a part of the standard coronary diagnostic toolkit of our catheterisation laboratories. As shown by the AID-ANGIO study, vasomotor disorders are highly prevalent in patients with chronic coronary syndromes referred for coronary angiography1. Since vasomotor derangements cannot be reliably diagnosed with non-invasive methods, ACh testing performed at the time of diagnostic angiography can be decisive in reaching a diagnosis in patients who, otherwise, may stay trapped in a never-ending loop of unsuccessful tests2. Once a diagnosis is made, patient symptoms may be successfully addressed using drugs like calcium channel blockers and nitrates. All this justifies why clinical practice guidelines recommend its use as part of functional testing for ischaemia with non-obstructive coronary arteries (INOCA)2.

In interpreting patients’ responses to ACh, the most widely used approach is that recommended by the Coronary Vasomotor Disorders International Study Group (COVADIS)3, which uses three different criteria for test positivity: (1) development of chest pain with anginal characteristics, (2) ischaemic electrocardiogram (ECG) changes, and (3) epicardial spasm ≥90% during the test....

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 6
Mar 17, 2025
Volume 21 Number 6
View full issue


Key metrics

Suggested by Cory

Clinical Research

10.4244/EIJ-D-21-00402 Feb 18, 2022
Principles and pitfalls in coronary vasomotor function testing
Feenstra R et al
free

Clinical Research

10.4244/EIJ-D-21-00875 Aug 5, 2022
Features of atherosclerosis in patients with angina and no obstructive coronary artery disease
Pellegrini D et al
free

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
Trending articles
200.45

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
58.7

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
39.45

Clinical research

10.4244/EIJ-D-23-00725 Nov 19, 2023
A systematic algorithm for large-bore arterial access closure after TAVI: the TAVI-MultiCLOSE study
Rosseel L et al
free
39.45

Original Research

10.4244/EIJ-D-23-00725 Mar 18, 2024
A systematic algorithm for large-bore arterial access closure after TAVI: the TAVI-MultiCLOSE study
Rosseel L et al
free
22.55

CLINICAL RESEARCH

10.4244/EIJV12I5A93 Aug 5, 2016
Longer pre-hospital delays and higher mortality in women with STEMI: the e-MUST Registry
Benamer H et al
free
22.55

INTERVENTIONAL FLASHLIGHT

10.4244/EIJ-D-17-00774 Oct 19, 2018
Ultra-low contrast percutaneous coronary intervention in patients with severe chronic kidney disease
Azzalini L et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved